Next » Journal of Microbiology, Immunology and Infection
Volume 45, Issue 1 , Pages 1-6 , February 2012

Role of moxifloxacin for the treatment of commmunity-acquired complicated intra-abdominal infections in Taiwan

Yeu-Jun Lau
- Division of Infectious Diseases, Department of Internal Medicine, Show-Chwan Memorial Hospital, Changhua, Taiwan
Yen-Hsu Chen
- Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Ching-Tai Huang
- Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan
Wen-Sen Lee
- Division of Infectious Diseases, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Cheng-Yi Liu
- Division of Infectious Diseases, Department of Internal Medicine, Taipei Veteran General Hospital, Taipei, Taiwan
Jien-Wei Liu
- Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital at Kaohsiung, Taiwan
Hsiao-Dong Liu
- Division of General Surgery, Department of Surgery, En Chu Kong Hospital, Xinbai, Taiwan
Yuarn-Jang Lee
- Division of Infectious Diseases, Department of Internal Medicine, Taipei Medical University Hospital, Taiwan
Chao-Wen Chen
- Division of Trauma, Department of Emergency, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Wen-Chien Ko
- Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan
Po-Ren Hsueh
- Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
- Corresponding author. Departments of Laboratory Medicine and Internal Medicine, National Taiwan University College of Medicine, 7 Chung Shan South Road, Taipei 100, Taiwan.

Received 24 October 2011 ,Revised 3 November 2011 ,Accepted 10 November 2011.

In vitro susceptibility of 10 antimicrobial agents against 610 isolates of Enterobacteriaceae recovered from patients treated at seven hospitals in Taiwan in 2009. Data were derived from Study for Mon

In vitro susceptibility of 10 antimicrobial agents against 610 isolates of Enterobacteriaceae recovered from patients treated at seven hospitals in Taiwan in 2009. Data were derived from Study for Monitoring Antimicrobial Resistance Trends (SMART).¹⁴
- Full-Size Image
- Download to PowerPoint
Rates of extended-spectrum β-lactamase (ESBL)-producing Escherchia coli and Klebsiella pneumoniae isolates recovered from patients (within or ≥48 h of admission) with intra-abdominal infections (IAIs)

Rates of extended-spectrum β-lactamase (ESBL)-producing Escherchia coli and Klebsiella pneumoniae isolates recovered from patients (within or ≥48 h of admission) with intra-abdominal infections (IAIs) who were treated at five hospitals in Taiwan that consistently participated in Study for Monitoring Antimicrobial Resistance Trends (SMART) program from 2006 to 2010 (A). Susceptibility rates to levofloxacin or ciprofloxacin among E. coli and K. pneumoniae isolates, collected within 48 h (B) and ≥48 h (C) of hospitalization, causing presumptively community-acquired IAIs at the five hospitals in Taiwan in from 2006 to 2010. Data were derived from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
- Full-Size Image
- Download to PowerPoint
(A) In vitro susceptibility of moxifloxacin and other six antimicrobial agents against 207 blood isolates of anaerobes (A) and against different species of anaerobes (B) recovered from patients treate

(A) In vitro susceptibility of moxifloxacin and other six antimicrobial agents against 207 blood isolates of anaerobes (A) and against different species of anaerobes (B) recovered from patients treated at national Taiwan University Hospital from 2006 to 2007.²⁴
- Full-Size Image
- Download to PowerPoint